Underwriting review support
Public claim records can help teams see what a business says, what support is visible, and where review questions may remain.
For Insurers & Acquirers
Claim records for diligence, underwriting, and portfolio review.
Scrutexity's AI Visibility Scanner architecture actively indexes and structures public-claim records for businesses where reputation, marketing language, and AI answer surfaces matter. The record is designed to inform institutional review workflows, not to replace counsel, underwriting judgment, or diligence advisors.
Acquisition diligence
Dated claim receipts give buyers a structured view of public-language risk before post-close marketing expansion.
Portfolio surveillance
Longitudinal review records can show claim drift, missing proof, and new public surfaces across operating companies.
Longitudinal Archive
Longitudinal Surveillance & Claim Drift Detection.
A one-time scan shows a surface at a moment in time. A Scrutexity archive shows how claim language, visible proof, and unresolved review notes change as a business grows, markets, raises, borrows, or acquires.
SOURCE
Public URL inventory
SOURCE
Observed claim text
ANALYSIS
Visible proof map
ANALYSIS
Evidence gap notes
REMEDIATION
Safer wording options
REMEDIATION
Open remediation log
PROVENANCE
Review timestamp
PROVENANCE
Record digest reference
Review Packet
Built to sit beside institutional review materials.
Scrutexity records can accompany underwriting memos, diligence folders, portfolio monitoring reports, and agency launch records. The artifact shows observed public language and visible proof gaps; it does not make legal or regulatory determinations.
Architecture is read-only by design. Scrutexity indexes public web surfaces — it never modifies them, never connects to practice management systems, and introduces zero integration surface into clinical or underwriting environments. Deployment is a DNS change, not a migration.
Boundary statement
Scrutexity outputs are structured public-claim review records. They are not legal opinions, valuation opinions, underwriting decisions, regulatory findings, clinical advice, or financial advice.